Results 251 to 260 of about 7,285,650 (306)

Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresis. [PDF]

Front Immunol
Martinez-Sanchez J, Charry P, Moreno-Castaño AB, Ramos A, Torramade-Moix S, Ventosa-Capell H, Palomo M, Penack O, Salas MQ, Suárez-Lledó M, Fernández-Avilés F, Martínez C, Rosiñol L, Rovira M, Carreras E, Lozano M, Escolar G, Cid J, Diaz-Ricart M.   +18 more
europepmc   +1 more source

Toxicity Differences Between Microplastics and Nanoplastics in Organs: From Molecular Mechanisms to Potential Therapeutic Strategies

Med Research, EarlyView.
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng, Junjie Chen, Rui Fu, Jiawei Zhang, Jianguang Jia, Wei Wang, Zheng Zhang, Peng Zhang, Haosong Chen, Huake Cao, Gang Li, Weiwei Sheng, Ting Li, Bo Chen, Guodong Cao   +14 more
wiley   +1 more source

Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial. [PDF]

Am J Hematol
Hamilton BK, Onstad L, Carpenter PA, Pidala J, Chen G, Cutler C, El Jurdi N, Farhadfar N, Juckett M, Kitko CL, Lee CJ, Lee SJ.   +11 more
europepmc   +1 more source

Organoid Coculture Models for Cancer Research and Immunotherapy

Med Research, EarlyView.
This review summarizes organoid coculture platforms, including submerged Matrigel culture, air–liquid interface, microfluidic/organoid‐on‐a‐chip, and 3D bioprinting, for reconstructing the tumor microenvironment to study tumor–stroma/immune crosstalk, evaluate immunotherapies, and enable drug screening.
Zhuo Yang, Huihui Yang, Guangxin Li, Guobang Liu, Zhulan Chen, Wenzhi Tian, Meiyang Huang, Xiaoling Liu, Yongsheng Zhao, Dong Chen   +9 more
wiley   +1 more source

Steroid-Refractory Chronic Graft-Versus-Host Disease-Associated Isolated Myositis Successfully Treated With Ruxolitinib: A Case Report. [PDF]

EJHaem
Kumamoto T, Yoshihara K, Matsuda I, Urase A, Ikunari R, Takahashi S, Samori M, Hirota S, Ohe C, Yoshihara S.   +9 more
europepmc   +1 more source

Introduction to graft-versus-host disease

Biology of Blood and Marrow Transplantation, 2005
openaire   +2 more sources

Fecal calprotectin as a biomarker for the diagnosis of gastrointestinal graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. [PDF]

Bone Marrow Transplant
Piñero-Pérez C, Velasco-Guardado A, Pérez-López E, Cortés-Rodríguez M, Cabrero-Calvo M, Martín-López AA, Sánchez-Guijo F, López-Corral L.   +7 more
europepmc   +1 more source

Severe Gastrointestinal Graft-versus-Host Disease Following Haploidentical Stem Cell Transplantation Presenting With Passage of a Colonic Cast. [PDF]

Gastro Hep Adv
Abubaker F, Adnan M, Almannai N, Butti N, Aljufairi E.   +4 more
europepmc   +1 more source

Extracorporeal photopheresis therapy for graft-versus-host disease with atypical neurological manifestations: a case report. [PDF]

Ann Hematol
Anelli L, Avenoso D.
europepmc   +1 more source